Introduction - Outcomes of GLP-1 RA in diabetes and cardiovascular disease - Discussing the key opportunities for cardiology practice
Topic:
Diabetes and the Heart
Speaker:
Professor T. Luscher (London, GB)
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Novo Nordisk
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Professor Thomas Felix Luscher
Royal Brompton Hospital Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
48
presentations
3
followers
3 more presentations in this session
Summary - GLP-1 receptor agonists - The cardiovascular benefits beyond glucose control.
Speaker: Professor S. Jacob (Villingen, DE)
Summary - Translating GLP-1 trial outcomes to cardiology practice - Which patients will benefit?
Speaker: Professor L. Ryden (Stockholm, SE)
Discussion - GLP-1 RA in diabetes and cardiovascular disease - What are the key opportunities for cardiology practice
Speaker: Professor T. Luscher (London, GB) Professor L. Ryden (Stockholm, SE) Professor S. Jacob (Villingen, DE)
Access the full session
Outcomes of GLP-1 RA in diabetes and cardiovascular disease - Discussing the key opportunities for cardiology practice
Speakers:
Professor T. Luscher, Professor S. Jacob, Professor L. Ryden, Professor T. Luscher, Professor L. Ryden...
About the event
ESC 365 is supported by
